0.93
price down icon2.09%   -0.0199
 
loading

Calcimedica Inc 주식(CALC)의 최신 뉴스

pulisher
Jul 11, 2026

CalciMedica Stock Short Interest Rises to 33.91% - Quiver Quantitative

Jul 11, 2026
pulisher
Jul 10, 2026

[Form 3] CalciMedica, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Jul 10, 2026
pulisher
Jul 10, 2026

Alafi Capital Discloses Investment at CalciMedica with 17.1% Stake - TradingView

Jul 10, 2026
pulisher
Jul 10, 2026

CalciMedica (CALC) gains 17.1% shareholder as Alafi Capital ups stake in $2.8M deal - Stock Titan

Jul 10, 2026
pulisher
Jul 09, 2026

calcimedica inc glp-1 receptor agonists weight management diabetes treatments GLP-1 Receptor Agonists: antidiabetic and weight loss management drugs: A Complete Review - news36live

Jul 09, 2026
pulisher
Jul 07, 2026

CalciMedica, Inc. Files Form 8-K with SEC: Key Company and Stock Information for July 2026 - Minichart

Jul 07, 2026
pulisher
Jul 07, 2026

CALC Q1 2026 Earnings: Surprise Positive EPS Amidst Revenue AbsenceBook Value Growth - dars.gov.et

Jul 07, 2026
pulisher
Jul 07, 2026

Form 4 CalciMedica Inc For: 7 July By Investing.com - Investing.com Nigeria

Jul 07, 2026
pulisher
Jul 07, 2026

Director at CalciMedica (CALC) granted stock options on 20,000 shares - Stock Titan

Jul 07, 2026
pulisher
Jul 07, 2026

CalciMedica (NASDAQ: CALC) director lists 2.1M shares and capped warrant holdings - Stock Titan

Jul 07, 2026
pulisher
Jul 07, 2026

CalciMedica Announces Board Expansion and Leadership Transition - TipRanks

Jul 07, 2026
pulisher
Jul 07, 2026

CalciMedica (NASDAQ: CALC) appoints Dr. Evgeny Zaytsev to board - Stock Titan

Jul 07, 2026
pulisher
Jul 07, 2026

CalciMedica, Inc. Announces Board Changes, Effective July 2, 2026 - marketscreener.com

Jul 07, 2026
pulisher
Jul 07, 2026

CALC Q1 2026 Earnings: Positive EPS Surprise Defies Expectations Amid Pre‑Revenue StatusPost-Earnings Reaction - dars.gov.et

Jul 07, 2026
pulisher
Jul 05, 2026

CALCCalciMedica Inc Options - Finviz

Jul 05, 2026
pulisher
Jul 02, 2026

CalciMedica (NASDAQ: CALC) gains 6.9% holder via June 2026 private placement - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Bering Partners II Discloses Investment at CalciMedica with 6.9% Stake - TradingView

Jul 02, 2026
pulisher
Jun 30, 2026

Form 13D/A CALCIMEDICA For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026
pulisher
Jun 30, 2026

CalciMedica (CALC) insiders add shares via open-market and unit purchases - Stock Titan

Jun 30, 2026
pulisher
Jun 29, 2026

Form 4 CalciMedica Inc For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026
pulisher
Jun 29, 2026

Calcimedica director Fred Middleton acquires $199,999 in stock. - Investing.com

Jun 29, 2026
pulisher
Jun 29, 2026

Calcimedica director Fred Middleton acquires $199,999 in stock. By Investing.com - Investing.com Australia

Jun 29, 2026
pulisher
Jun 29, 2026

CalciMedica (CALC) chief business officer gets 186,729-share stock award at $0.8033 - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

CalciMedica (CALC) insider-affiliated fund buys 248,972 new shares at $0.8033 - Stock Titan

Jun 29, 2026
pulisher
Jun 27, 2026

FDA raises no concerns over Auxora safety data, CalciMedica advances trial - MSN

Jun 27, 2026
pulisher
Jun 25, 2026

CalciMedica (NASDAQ: CALC) lenders capped at 4.99% ownership after loan amendment - Stock Titan

Jun 25, 2026
pulisher
Jun 25, 2026

Key facts: CalciMedica $15M raise; Auxora paused, FDA feedback due Q3 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

CalciMedica Receives FDA Clearance to Resume Auxora Clinical Trial for Acute Kidney Injury After Safety Review - Minichart

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Announces Private Placement Financing for Up to About $49M to Advance Pulmonary Hypertension Program - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Advances Auxora After Favorable FDA Safety Review - TipRanks

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica (Nasdaq: CALC) raises $15M, maps PAH and PH trial plans - Stock Titan

Jun 24, 2026
pulisher
Jun 24, 2026

H.C. Wainwright Maintains CalciMedica(CALC.US) With Hold Rating - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica says FDA allows KOURAGE trial to continue - grafa.com

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica receives FDA clearance to continue Auxora trial By Investing.com - Investing.com Australia

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica, Inc. Announces Amendments to Loan and Warrant Agreements with Avenue Venture Opportunities Fund II, L.P – Minichart - Minichart

Jun 24, 2026
pulisher
Jun 24, 2026

$CalciMedica (CALC.US)$ - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

What's Going On With CalciMedica Stock Wednesday?CalciMedica (NASDAQ:CALC) - Benzinga

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica secures up to $49M private placement financing - Investing.com

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica receives FDA clearance to continue Auxora trial - Investing.com

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica: Proceeds Expected to Support Pulmonary Hypertension Strategy, Including Phase 1b POC Study Evaluating Auxora in PAH, With Data Anticipated Mid-2027, and Advancement of Oral CRAC Channel Inhibitor CM5480 to IND Clearance Expecte - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review - marketscreener.com

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica to Sell 18.7M Units >CALC - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data - The AI Journal

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Entered Into Definitive Securities Purchase Agreement With Leading Healthcare Investors >CALC - Moomoo

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Amends Loan, Issues New Equity Warrants - TipRanks

Jun 24, 2026
pulisher
Jun 24, 2026

Calcimedica Announces Private Placement Financing For Up To Approximately $49 Million To Advance Pulmonary Hypertension Program - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program - 富途牛牛

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica Extends $10M Loan, Adds $3M Conversion; Issues New $1.00 Warrants - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

CalciMedica (NASDAQ: CALC) extends Avenue loan and issues new $1.00 warrants - Stock Titan

Jun 24, 2026
pulisher
Jun 18, 2026

CALC News | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill

Jun 18, 2026
$56.43
price down icon 2.64%
$115.61
price down icon 2.24%
$35.97
price down icon 2.28%
$68.27
price down icon 10.83%
ONC ONC
$298.70
price down icon 1.36%
$186.88
price down icon 2.22%
자본화:     |  볼륨(24시간):